Comprehensive Myositis Antibody Panels Improve Recognition of Myositis Related Interstitial Lung Disease

被引：0
|
作者：
Davis, A. E. [1 ]
Hewlett, J. C. [2 ]
Dudenhofer, R. B. [2 ]
Crofford, L. J. [3 ]
Wilfong, E. M. [2 ]
机构：
[1] Vanderbilt Univ, Internal Med Residency Program, Med Ctr, Nashville, TN USA
[2] Vanderbilt Univ, Div Allergy Pulm & Crit Care, Med Ctr, Nashville, TN USA
[3] Vanderbilt Univ, Div Rheumatol & Immunol, Med Ctr, Nashville, TN USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2023年 / 207卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A4190
引用
收藏
页数：2
相关论文
共 50 条
  • [41] MYOSITIS AUTOANTIBODIES PANEL AND INTERSTITIAL LUNG DISEASE: PATTERNS AND CORRELATION
    Farah, Wigdan
    Alrehaili, Ghadah
    Baqir, Misbah
    CHEST, 2023, 164 (04) : 3148A - 3148A
  • [42] EFFICACY AND SAFETY OF ABATACEPT IN MYOSITIS ASSOCIATED INTERSTITIAL LUNG DISEASE
    Aggarwal, R.
    Moghadam-Kia, S.
    Koontz, D.
    Saygin, D.
    Bae, S.
    Sullivan, D.
    Marder, G.
    Venuturupalli, S.
    Dellaripa, P.
    Danoff, S.
    Doyle, T.
    Hunninghake, G.
    Lee, J. S.
    Fischer, A.
    Falk, J.
    Kang, C. R.
    Lin, Y.
    Johnson, C.
    Ascherman, D.
    Oddis, C. V.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 959 - 959
  • [43] Prognostic Factors for Myositis-Associated Interstitial Lung Disease
    Fujisawa, Tomoyuki
    Hozumi, Hironao
    Kono, Masato
    Enomoto, Noriyuki
    Hashimoto, Dai
    Nakamura, Yutaro
    Inui, Naoki
    Yokomura, Koshi
    Koshimizu, Naoki
    Toyoshima, Mikio
    Shirai, Toshihiro
    Yasuda, Kazumasa
    Hayakawa, Hiroshi
    Suda, Takafumi
    PLOS ONE, 2014, 9 (06):
  • [44] The Influence of Specific Myositis Antibodies on the Development of Interstitial Lung Disease
    Lan, Ting-Yuan
    Lee, Tai-Ju
    Lin, Kuan-Yen
    Kao, Jui-Hung
    Cheng, Chiao-Feng
    Lu, Cheng-Hsun
    Shen, Chieh-Yu
    Li, Ko-Jen
    Hsieh, Song-Chou
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 3860 - 3862
  • [45] Clinical significance of myositis specific antibodies in interstitial lung disease
    Krummenacher, J.
    Loo, Y.
    Krummenacher, M.
    Boardman, G.
    Stevenson, B.
    Wrobel, J.
    RESPIROLOGY, 2023, 28 : 199 - 199
  • [46] Interstitial Lung Disease in Myositis: Clinical Subsets, Biomarkers, and Treatment
    Tsuneyo Mimori
    Ran Nakashima
    Yuji Hosono
    Current Rheumatology Reports, 2012, 14 : 264 - 274
  • [47] Interstitial Lung Disease in Myositis: Clinical Subsets, Biomarkers, and Treatment
    Mimori, Tsuneyo
    Nakashima, Ran
    Hosono, Yuji
    CURRENT RHEUMATOLOGY REPORTS, 2012, 14 (03) : 264 - 274
  • [48] Management of Interstitial Lung Disease in Patients With Myositis Specific Autoantibodies
    Mecoli, Christopher A.
    Christopher-Stine, Lisa
    CURRENT RHEUMATOLOGY REPORTS, 2018, 20 (05)
  • [49] Significance of Myositis Autoantibody in Patients with Idiopathic Interstitial Lung Disease
    Song, Ju Sun
    Hwang, Jiwon
    Cha, Hoon-Suk
    Jeong, Byeong-Ho
    Suh, Gee Young
    Chung, Man Pyo
    Kang, Eun-Suk
    YONSEI MEDICAL JOURNAL, 2015, 56 (03) : 676 - 683
  • [50] Myositis beyond muscle: Clinical patterns and prognostic factors in myositis-associated interstitial lung disease
    Wong, Yen Shen
    Muhammad, Noorul Afidza
    Musa, Aisya Natasya
    Tan, Chen Yong
    Vasudayan, Shoban Raj
    Rosli, Fatimah Zaharah
    SarbanSingh, Karamjit Kaur
    Ahmad, Haly Rozie
    Appava, Sumithra
    Lam, Chun Hau
    Wan, Jen Lye
    Chng, Shereen Suyin
    Dashuki, Nuruliman
    Rahman, Jamalul Azizi Abdul
    RESPIROLOGY, 2024, 29 : 28 - 28
12345